MARKET

OPRX

OPRX

OPTIMIZERX
NASDAQ

Real-time Quotes | Nasdaq Last Sale

44.56
-0.47
-1.04%
After Hours: 44.56 0 0.00% 16:51 05/11 EDT
OPEN
41.26
PREV CLOSE
45.03
HIGH
45.42
LOW
41.00
VOLUME
227.90K
TURNOVER
--
52 WEEK HIGH
63.98
52 WEEK LOW
9.21
MARKET CAP
770.01M
P/E (TTM)
-1053.4279
1D
5D
1M
3M
1Y
5Y
OptimizeRx to Present at RBC Capital Markets Global Virtual Healthcare Conference on May 19, 2021
ROCHESTER, May 11, 2021 (GLOBE NEWSWIRE via COMTEX) -- ROCHESTER, Mich., May 11, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a...
GlobeNewswire · 17h ago
RBC Capital Sticks to Its Buy Rating for OptimizeRx (OPRX)
SmarterAnalyst · 2d ago
DJ OptimizeRx Corporation CEO William Febbo on Q1 2021 Results -- Earnings Call Transcript >OPRX
Dow Jones · 2d ago
8-K: OptimizeRx Corp
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ____________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 4d ago
--B. Riley Raises OptimizeRx' Price Target to $80 from $75 on Q1 Results, Keeps Buy Rating
MT Newswires · 4d ago
OptimizeRx Corp. (OPRX) Q1 Earnings and Revenues Beat Estimates
Zacks.com · 5d ago
OptimizeRx Q1 EPS $0.03 Beats $0.01 Estimate, Sales $11.20M Beat $10.47M Estimate
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.01 by 200 percent. This is a 150 percent increase over losses of $(0.06) per share from the same
Benzinga · 5d ago
OptimizeRx EPS beats by $0.03, beats on revenue
OptimizeRx (OPRX): Q1 Non-GAAP EPS of $0.04 beats by $0.03; GAAP EPS of -$0.04 beats by $0.02.Revenue of $11.23M (+48.2% Y/Y) beats by $0.76M.Shares +0.5%.Press Release
Seekingalpha · 5d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OPRX. Analyze the recent business situations of OPTIMIZERX through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OPRX stock price target is 74.00 with a high estimate of 85.00 and a low estimate of 65.00.
EPS
Institutional Holdings
Institutions: 112
Institutional Holdings: 11.23M
% Owned: 66.79%
Shares Outstanding: 17.28M
TypeInstitutionsShares
Increased
32
666.82K
New
23
590.61K
Decreased
23
941.96K
Sold Out
5
63.71K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Online Services
-0.06%
Software & IT Services
+0.27%
Key Executives
Chairman/Director
Gus Halas
President
Miriam Paramore
Chief Executive Officer/Director
William Febbo
Chief Financial Officer
Douglas Baker
Senior Vice President
Angelo Campano
Chief Technology Officer
Todd Inman
Chief Compliance Officer/General Counsel
Marion Odence-Ford
Other
Stephen Silvestro
Director
Gregory Wasson
Independent Director
James Lang
Independent Director
Patrick Spangler
Independent Director
Lynn Vos
No Data
About OPRX
OptimizeRx Corporation is a digital health company that facilitates communication at point-of-care among stakeholders in healthcare. The Company provides electronic clinical information through electronic health records (EHRs) to the medical profession, providing a direct channel for pharmaceutical companies to communicate with healthcare providers. Primarily focused on life science and payer clients, its suite of digital and mobile software as a service (SaaS)-based solutions enables affordability, patient adherence and care management. The Company’s products and applications include financial messaging, brand and clinical messaging, brand support, patient engagement and digital therapeutics. Its integrated financial messaging platform is a virtual patient support center that allows doctors and staff to access a universe of sample vouchers, co-pay coupons and other patient support through their electronic medical record (EMR) and/or e-Prescribe systems.

Webull offers kinds of OptimizeRx Corporation stock information, including NASDAQ:OPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OPRX stock methods without spending real money on the virtual paper trading platform.